These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 33824468)

  • 1. Allelic and phenotypic heterogeneity in Junctophillin-3 related neurodevelopmental and movement disorders.
    Bourinaris T; Athanasiou A; Efthymiou S; Wiethoff S; Salpietro V; Houlden H
    Eur J Hum Genet; 2021 Jun; 29(6):1027-1031. PubMed ID: 33824468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Junctophilin 3 (JPH3) expansion mutations causing Huntington disease like 2 (HDL2) are common in South African patients with African ancestry and a Huntington disease phenotype.
    Krause A; Mitchell C; Essop F; Tager S; Temlett J; Stevanin G; Ross C; Rudnicki D; Margolis R
    Am J Med Genet B Neuropsychiatr Genet; 2015 Oct; 168(7):573-85. PubMed ID: 26079385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of junctophilin-3 contributes to Huntington disease-like 2 pathogenesis.
    Seixas AI; Holmes SE; Takeshima H; Pavlovich A; Sachs N; Pruitt JL; Silveira I; Ross CA; Margolis RL; Rudnicki DD
    Ann Neurol; 2012 Feb; 71(2):245-57. PubMed ID: 22367996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Huntington's disease like-2: review and update.
    Margolis RL; Rudnicki DD; Holmes SE
    Acta Neurol Taiwan; 2005 Mar; 14(1):1-8. PubMed ID: 15835282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Drosophila model of Huntington disease-like 2 exhibits nuclear toxicity and distinct pathogenic mechanisms from Huntington disease.
    Krench M; Cho RW; Littleton JT
    Hum Mol Genet; 2016 Aug; 25(15):3164-3177. PubMed ID: 27288455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A repeat expansion in the gene encoding junctophilin-3 is associated with Huntington disease-like 2.
    Holmes SE; O'Hearn E; Rosenblatt A; Callahan C; Hwang HS; Ingersoll-Ashworth RG; Fleisher A; Stevanin G; Brice A; Potter NT; Ross CA; Margolis RL
    Nat Genet; 2001 Dec; 29(4):377-8. PubMed ID: 11694876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Huntington's disease-like 2 with an expansion mutation of the Junctophilin-3 gene; first reported case from Botswana.
    Ocampo C; Daimari R; Oyekunle AA
    J Clin Neurosci; 2018 Jan; 47():126-127. PubMed ID: 29066237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Huntington disease-like 2: insight into neurodegeneration from an African disease.
    Krause A; Anderson DG; Ferreira-Correia A; Dawson J; Baine-Savanhu F; Li PP; Margolis RL
    Nat Rev Neurol; 2024 Jan; 20(1):36-49. PubMed ID: 38114648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A South African mixed ancestry family with Huntington disease-like 2: clinical and genetic features.
    Bardien S; Abrahams F; Soodyall H; van der Merwe L; Greenberg J; Brink T; Carr J
    Mov Disord; 2007 Oct; 22(14):2083-9. PubMed ID: 17708569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Huntington's disease-like phenotype due to trinucleotide repeat expansions in the TBP and JPH3 genes.
    Stevanin G; Fujigasaki H; Lebre AS; Camuzat A; Jeannequin C; Dode C; Takahashi J; San C; Bellance R; Brice A; Durr A
    Brain; 2003 Jul; 126(Pt 7):1599-603. PubMed ID: 12805114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clustered mutations in the GRIK2 kainate receptor subunit gene underlie diverse neurodevelopmental disorders.
    Stolz JR; Foote KM; Veenstra-Knol HE; Pfundt R; Ten Broeke SW; de Leeuw N; Roht L; Pajusalu S; Part R; Rebane I; Õunap K; Stark Z; Kirk EP; Lawson JA; Lunke S; Christodoulou J; Louie RJ; Rogers RC; Davis JM; Innes AM; Wei XC; Keren B; Mignot C; Lebel RR; Sperber SM; Sakonju A; Dosa N; Barge-Schaapveld DQCM; Peeters-Scholte CMPCD; Ruivenkamp CAL; van Bon BW; Kennedy J; Low KJ; Ellard S; Pang L; Junewick JJ; Mark PR; Carvill GL; Swanson GT
    Am J Hum Genet; 2021 Sep; 108(9):1692-1709. PubMed ID: 34375587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Huntington's Disease-like 2 (HDL2) in North America and Japan.
    Margolis RL; Holmes SE; Rosenblatt A; Gourley L; O'Hearn E; Ross CA; Seltzer WK; Walker RH; Ashizawa T; Rasmussen A; Hayden M; Almqvist EW; Harris J; Fahn S; MacDonald ME; Mysore J; Shimohata T; Tsuji S; Potter N; Nakaso K; Adachi Y; Nakashima K; Bird T; Krause A; Greenstein P
    Ann Neurol; 2004 Nov; 56(5):670-4. PubMed ID: 15468075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expanding the Spectrum of Genes Involved in Huntington Disease Using a Combined Clinical and Genetic Approach.
    Mariani LL; Tesson C; Charles P; Cazeneuve C; Hahn V; Youssov K; Freeman L; Grabli D; Roze E; Noël S; Peuvion JN; Bachoud-Levi AC; Brice A; Stevanin G; Durr A
    JAMA Neurol; 2016 Sep; 73(9):1105-14. PubMed ID: 27400454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and molecular heterogeneity of VPS13D-related neurodevelopmental and movement disorders.
    Sultan T; Scorrano G; Panciroli M; Christoforou M; Raza Alvi J; Di Ludovico A; Qureshi S; Efthymiou S; Salpietro V; Houlden H
    Gene; 2024 Mar; 899():148119. PubMed ID: 38160741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exclusion of mutations in the PRNP, JPH3, TBP, ATN1, CREBBP, POU3F2 and FTL genes as a cause of disease in Portuguese patients with a Huntington-like phenotype.
    Costa MDC; Teixeira-Castro A; Constante M; Magalhães M; Magalhães P; Cerqueira J; Vale J; Passão V; Barbosa C; Robalo C; Coutinho P; Barros J; Santos MM; Sequeiros J; Maciel P
    J Hum Genet; 2006; 51(8):645-651. PubMed ID: 16858508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disruption of SOX6 is associated with a rapid-onset dopa-responsive movement disorder, delayed development, and dysmorphic features.
    Ebrahimi-Fakhari D; Maas B; Haneke C; Niehues T; Hinderhofer K; Assmann BE; Runz H
    Pediatr Neurol; 2015 Jan; 52(1):115-8. PubMed ID: 25439488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The
    Calpena E; López Del Amo V; Chakraborty M; Llamusí B; Artero R; Espinós C; Galindo MI
    Dis Model Mech; 2018 Jan; 11(1):. PubMed ID: 29208631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Huntington disease-like 2 (HDL2) in Venezuela: frequency and ethnic origin.
    Paradisi I; Ikonomu V; Arias S
    J Hum Genet; 2013 Jan; 58(1):3-6. PubMed ID: 22971727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Huntington's disease--like 2 is associated with CUG repeat-containing RNA foci.
    Rudnicki DD; Holmes SE; Lin MW; Thornton CA; Ross CA; Margolis RL
    Ann Neurol; 2007 Mar; 61(3):272-82. PubMed ID: 17387722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exome sequencing analysis in a pair of monozygotic twins re-evaluates the genetics behind their intellectual disability and reveals a CHD2 mutation.
    Pinto AM; Bianciardi L; Mencarelli MA; Imperatore V; Di Marco C; Furini S; Suppiej A; Salviati L; Tenconi R; Ariani F; Mari F; Renieri A
    Brain Dev; 2016 Jun; 38(6):590-6. PubMed ID: 26754451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.